Acquiring Company
GE HealthCare Technologies
Acquired Company
SOFIE Biosciences
ChicagoLos AngelesOtherInformation TechnologyBiotechnologyHealth CareMedicalMedical DeviceHealth DiagnosticsBiotechnologyDescription
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition aims to establish a 'Final Mile' footprint for PET radiopharmaceutical supply in the U.S. The transaction is expected to close in the first half of 2027, pending regulatory approvals. SOFIE will become part of GE HealthCare’s PDx segment upon completion.
Quick answer
GE HealthCare Technologies is acquiring SOFIE Biosciences for $945 million, announced October 5, 2026. GE HealthCare Technologies is based in Chicago, Illinois, United States.
- How much did GE HealthCare Technologies pay for SOFIE Biosciences?
- The reported deal value is $945 million.
- What does GE HealthCare Technologies do?
- GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions.
- Where are GE HealthCare Technologies and SOFIE Biosciences based?
- GE HealthCare Technologies is based in Chicago, Illinois, United States. SOFIE Biosciences is based in Los Angeles, California, United States.
- Who are the decision-makers at GE HealthCare Technologies?
- Fundz holds 5 contacts at GE HealthCare Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cent acquires AI radiology platform Medsee (October 27, 2026)
- Bedfont® acquires coVita™ to enhance US presence (October 13, 2026)
- Lifecore Biomedical Announces Merger with Lifecore Inc. (September 27, 2026)
- Integral Diagnostics successfully merges with Capitol Health (August 25, 2026)
- Rockwell Medical, Inc. to Acquire Vantive Limited's Hemodialysis Business (November 3, 2026)
- AddLife acquires Portuguese distributor MoonSurge (November 2, 2026)
Who to call at GE HealthCare Technologies, and when
When GE HealthCare Technologies changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day GE HealthCare Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GE HealthCare Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GE HealthCare Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GE HealthCare Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SOFIE Biosciences?
SOFIE Biosciences was acquired by GE HealthCare Technologies, based in Chicago. The deal was reported on October 5, 2026. GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. GE HealthCare Technologies is publicly traded (GEHC) and operates in Other.
When did GE HealthCare Technologies acquire SOFIE Biosciences?
GE HealthCare Technologies's acquisition of SOFIE Biosciences was reported on October 5, 2026. GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition aims to establish a 'Final Mile' footprint for PET radiopharmaceutical supply in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SOFIE Biosciences do?
SOFIE Biosciences is a leading innovator in the field of radiopharmaceuticals. The company develops advanced imaging agents for cancer diagnosis and treatment. Its products aim to improve the accuracy and effectiveness of diagnostic imaging. It is privately held, operating in Biotechnology, and is based in Los Angeles.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.